Nexgel Net Worth
Nexgel Net Worth Breakdown | NXGL |
Nexgel Net Worth Analysis
Nexgel's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Nexgel's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Nexgel's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Nexgel's net worth analysis. One common approach is to calculate Nexgel's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Nexgel's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Nexgel's net worth. This approach calculates the present value of Nexgel's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Nexgel's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Nexgel's net worth. This involves comparing Nexgel's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Nexgel's net worth relative to its peers.
Enterprise Value |
|
To determine if Nexgel is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Nexgel's net worth research are outlined below:
| Nexgel Inc generated a negative expected return over the last 90 days | |
| Nexgel Inc has high historical volatility and very poor performance | |
| Nexgel Inc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 4.09 M. Net Loss for the year was (3.16 M) with profit before overhead, payroll, taxes, and interest of 2.13 M. | |
| Nexgel Inc currently holds about 9.79 M in cash with (3.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.76. | |
| Nexgel Inc has a poor financial position based on the latest SEC disclosures | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on ... |
Nexgel Quarterly Good Will |
|
Nexgel uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Nexgel Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Nexgel's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 25th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Nexgel Target Price Consensus
Nexgel target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Nexgel's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| One | Buy |
Most Nexgel analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Nexgel stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Nexgel Inc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationNexgel Target Price Projection
Nexgel's current and average target prices are 2.88 and 6.00, respectively. The current price of Nexgel is the price at which Nexgel Inc is currently trading. On the other hand, Nexgel's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Nexgel Target Price
Know Nexgel's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Nexgel is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nexgel Inc backward and forwards among themselves. Nexgel's institutional investor refers to the entity that pools money to purchase Nexgel's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Sbi Securities Co Ltd | 2024-12-31 | 607 | Advisor Group Holdings, Inc. | 2024-12-31 | 310 | Bank Of America Corp | 2024-12-31 | 44.0 | Jpmorgan Chase & Co | 2024-12-31 | 12.0 | Susquehanna International Group, Llp | 2024-09-30 | 0.0 | Ubs Group Ag | 2024-12-31 | 0.0 | Renaissance Technologies Corp | 2024-12-31 | 158.3 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 87.8 K | Geode Capital Management, Llc | 2024-12-31 | 60.1 K | Vanguard Group Inc | 2024-12-31 | 50 K | Massey, Quick & Co. Llc | 2024-12-31 | 35.7 K |
Follow Nexgel's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.95 M.Market Cap |
|
Project Nexgel's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.33) | (0.35) | |
| Return On Capital Employed | (0.42) | (0.44) | |
| Return On Assets | (0.29) | (0.30) | |
| Return On Equity | (0.60) | (0.64) |
When accessing Nexgel's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Nexgel's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Nexgel's profitability and make more informed investment decisions.
Evaluate Nexgel's management efficiency
Nexgel Inc has return on total asset (ROA) of (0.2395) % which means that it has lost $0.2395 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6807) %, meaning that it created substantial loss on money invested by shareholders. Nexgel's management efficiency ratios could be used to measure how well Nexgel manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.35. The value of Return On Capital Employed is expected to slide to -0.44. At this time, Nexgel's Intangible Assets are quite stable compared to the past year. Debt To Assets is expected to rise to 0.40 this year, although the value of Total Current Assets will most likely fall to about 3.9 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.82 | 0.48 | |
| Tangible Book Value Per Share | 0.59 | 0.44 | |
| Enterprise Value Over EBITDA | (4.02) | (4.22) | |
| Price Book Value Ratio | 2.31 | 2.20 | |
| Enterprise Value Multiple | (4.02) | (4.22) | |
| Price Fair Value | 2.31 | 2.20 | |
| Enterprise Value | 11 M | 10.4 M |
At Nexgel Inc, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Enterprise Value Revenue 3.1423 | Revenue | Quarterly Revenue Growth 1.408 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nexgel insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nexgel's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nexgel insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nexgel Corporate Filings
F4 | 11th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 22nd of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 13th of November 2024 Other Reports | ViewVerify | |
10Q | 19th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Nexgel Earnings Estimation Breakdown
The calculation of Nexgel's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Nexgel is estimated to be 0.0 with the future projection ranging from a low of 0.0 to a high of 0.0. Please be aware that this consensus of annual earnings estimates for Nexgel Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.00 Lowest | Expected EPS | 0.00 Highest |
Nexgel Earnings Projection Consensus
Suppose the current estimates of Nexgel's value are higher than the current market price of the Nexgel stock. In this case, investors may conclude that Nexgel is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Nexgel's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 1 | 77.73% | -0.11 | 0.0 | -0.59 |
Nexgel Earnings per Share Projection vs Actual
Actual Earning per Share of Nexgel refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Nexgel Inc predict the company's earnings will be in the future. The higher the earnings per share of Nexgel, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Nexgel Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Nexgel, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Nexgel should always be considered in relation to other companies to make a more educated investment decision.Nexgel Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Nexgel's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-14 | 2024-09-30 | -0.1 | -0.11 | -0.01 | 10 | ||
2024-08-15 | 2024-06-30 | -0.14 | -0.1455 | -0.0055 | 3 | ||
2024-05-13 | 2024-03-31 | -0.18 | -0.14 | 0.04 | 22 | ||
2024-03-18 | 2023-12-31 | -0.11 | -0.21 | -0.1 | 90 | ||
2023-11-13 | 2023-09-30 | -0.12 | -0.1 | 0.02 | 16 | ||
2023-08-14 | 2023-06-30 | -0.13 | -0.12 | 0.01 | 7 | ||
2023-05-15 | 2023-03-31 | -0.14 | -0.15 | -0.01 | 7 | ||
2023-03-27 | 2022-12-31 | -0.15 | -0.11 | 0.04 | 26 | ||
2022-11-08 | 2022-09-30 | -0.15 | -0.21 | -0.06 | 40 | ||
2022-08-10 | 2022-06-30 | -0.15 | -0.19 | -0.04 | 26 | ||
2022-05-12 | 2022-03-31 | -0.15 | -0.33 | -0.18 | 120 | ||
2022-03-21 | 2021-12-31 | -0.37 | -0.52 | -0.15 | 40 | ||
2021-11-10 | 2021-09-30 | 0 | -0.21 | -0.21 | 0 | ||
2021-08-16 | 2021-06-30 | 0 | -0.15 | -0.15 | 0 | ||
2021-05-17 | 2021-03-31 | 0 | -0.13 | -0.13 | 0 |
Nexgel Corporate Management
| Joseph McGuire | Chief Officer | Profile | |
| David Stefansky | Ex Director | Profile | |
| Adam III | Chief Officer | Profile | |
| Gregory Robb | Vice Operations | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Revenue Per Share | Quarterly Revenue Growth 1.408 | Return On Assets | Return On Equity |
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.